Healio’s top retina items last year included the FDA approvals of Syfovre for geographic atrophy and Eylea HD for wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.
Check out the most popular retina/vitreous items from 2023 below.
FDA approves Syfovre – first treatment for geographic atrophy, a leading cause of blindness
Apellis Pharmaceuticals announced the FDA approved its product Syfovre, also known as pegcetacoplan injection, for the treatment of geographic atrophy secondary to age-related macular degeneration. Read more.
FDA approves Eylea HD